Certified by Founder Lodge
AGLAÉ VENTURES
France - Paris, Île-de-France
INVESTOR
1 Disclosed Funding Rounds $55,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Aglaé Ventures is a venture capital firm based in Paris, New York and San Francisco backed by Groupe Arnault, the controlling shareholder of LVMH, global leader in luxury goods.
Aglaé Ven
| Company | Date | Round | Raised |
|---|---|---|---|
Pachama |
May, 05 ,2022 | Series B | $55,000,000 |
Open |
January, 31 ,2022 | Series A | $14,500,000 |
Back Market |
January, 12 ,2022 | Series E | $510,000,000 |
Zealy |
April, 06 ,2023 | Pre-Seed | $3,500,000 |
Mooncard |
April, 24 ,2023 | Series C | $40,715,000 |
RISC Zero |
July, 20 ,2023 | Series A | $40,000,000 |
Certa |
September, 08 ,2023 | Series B | $35,000,000 |
Shimmer |
January, 12 ,2024 | Seed | $2,200,000 |
Sonarverse |
March, 08 ,2024 | Seed | $7,000,000 |
Borderless AI |
March, 22 ,2024 | Seed | $27,000,000 |
Proxima |
April, 03 ,2024 | Series A | $12,000,000 |
Belfry |
January, 22 ,2025 | Series A | $12,000,000 |
Pachama
Open
Back Market
Zealy
Mooncard
RISC Zero
Certa
Shimmer
Sonarverse
Borderless AI
Proxima
Belfry
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)